Novadip Biosciences

About:

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

Top Investors: New Science Ventures, S.R.I.W., CR-CP Life Science Fund, Fund+, Invest BW

Description:

Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.

Total Funding Amount:

87M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Mont-saint-guibert, Brabant Wallon, Belgium

Founded Date:

2013-01-01

Contact Email:

info(AT)novadip.com

Founders:

Denis Dufrane, Jean- François Pollet

Number of Employees:

11-50

Last Funding Date:

2022-11-03

IPO Status:

Private

Industries: